Dr. Van Huynh, pediatric oncologist at the Hyundai Cancer Institute at CHOC Children's, plays with a young patient

The forefront of CAR T-Cell immunotherapy research for high-risk pediatric leukemia patients

Along with providing access to clinical trials for CAR T-cell therapy and other immunotherapy, CHOC is a certified KYMRIAH treatment center.

CHOC Pediatrica